Platelet inhibiting drugs in eyelid surgery.

The continuation of platelet inhibiting drugs in eyelid surgery. An observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29088

Enrollment

324

Registered

2009-08-04

Start date

2009-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyelid surgery, Platelet inhibitors, Haemorrhagic complications. Trefwoorden NL: Ooglidchirurgie, Plaatjesaggregatieremmers, Haemorrhagische complicaties.

Interventions

None.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Use of platelet inhibiting drugs. 2. Scheduled for surgical correction of ectropion or entropion, or for non-cosmetic upperlid blepharoplasty without fat excision.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
1. Peroperative bleeding; 2. Postoperative bleeding; 3. Other postoperative adverse event.	—

Secondary

Measure	Time frame
1. Retrobulbar haemorrhage; 2. Result of surgery; 3. Reduced visual acuity; 4. Cardiac or cerebral ischaemic event.	—

Contacts

Public ContactO. Weijtens

Het Oogziekenhuis Rotterdam, Postbus 70030

r.wubbels@oogziekenhuis.nl+31 (0)10 4017777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)